Boston Millennia Portfolio Company, Histogenics, Completes Successful IPO

Millennia Portfolio Company, Histogenics, a regenerative medicine company, today announced the pricing of its underwritten initial public offering of 5,909,091 shares of its common stock at a price to the public of $11.00 per share.